Poster: Prospective evaluation of the SeptiCyte® Rapid assay for the identification of systemic infectious diseases in patients with suspected sepsis

Saarland Poster - Barcelona 2024

Researchers from the Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany, and the Department of Internal Medicine V, Pneumology and Intensive Care Medicine, Sashand University, Homburg, Germany presented a poster at the European Congress of Clinical Microbiology and Infectious Diseases at the 2024 annual meeting in Barcelona. Download the Saarland poster here

Read More

Independent Studies Presented at ESCMID Global Demonstrate the Clinical Utility of SeptiCyte® RAPID in Patients Suspected of Sepsis, Including in Polytrauma Patients

Immunexpress - the signature diagnostics for sepsis

SeptiCyte® RAPID accurately differentiated between nosocomial infections and systemic inflammatory response syndrome in polytrauma ICU patients suspected of sepsis. SeptiScore® was elevated in ICU patients suspected of sepsis when a causative pathogen was identified. SEATTLE and BRISBANE, Australia, April 17, 2024 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis…

Read More